Want to see PYYX full AI Analyst Report?
Pyxus International (PYYX) AI Stock Analysis
Pyxus International
(Other OTC:PYYX)
The score is held back primarily by weak financial quality—high leverage, thin equity, and negative operating/free cash flow alongside a sharp TTM revenue decline. Valuation is a key offset with a very low P/E, while technicals remain weak-to-neutral (below 20/50-day averages with negative MACD). The latest earnings call provides some support via reaffirmed guidance and improving credit metrics, but refinancing uncertainty and softer YoY sales keep risk elevated.
Pyxus International (PYYX) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $62.26M
- Dividend Yield
- ―
- Average Volume (3M)
- 4,647
- Price to Earnings (P/E)
- 2.8
- Beta (1Y)
- 0.08
- Revenue Growth
- -0.56%
- EPS Growth
- ―
- Country
- US
- Employees
- 3,300
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
Pyxus International Business Overview & Revenue Model
Company Description
Pyxus International, Inc. operates as an agricultural enterprise, delivering specialized products and services to a diverse range of business and individual clients. A core part of its operations involves managing the entire supply chain for tobacco...
How the Company Makes Money
Pyxus International makes money primarily by selling processed leaf tobacco to tobacco product manufacturers. Its revenue model is largely business-to-business and centers on (1) purchasing green tobacco leaf from growers (often in multiple origin co...
Pyxus International Earnings Call Summary
The call emphasized disciplined execution, improved cash generation, stronger rolling 12-month adjusted EBITDA, better leverage and liquidity, and progress on agricultural innovation. Near-term challenges include a notable year-over-year decline in quarterly sales, modest decreases in quarterly EBITDA and gross margin dollars, higher SG&A, a longer operating cycle, and outstanding long-term debt refinancing uncertainty. Management reiterated guidance and highlighted balance sheet improvement as a key focus.
Q1-2027 Updates
Positive Updates
Negative Updates
Company Guidance
The company reaffirmed its full‑year fiscal 2027 guidance, saying shipment volumes should strengthen over the remaining nine months with a cadence broadly consistent with last year and the full‑year outlook unchanged; Q1 metrics cited included sales of $437.8M (vs $508.8M prior year), gross margin $61.4M (14.0% vs 12.9%) and gross profit per kilo $0.84 (vs $0.86), SG&A $43.9M, adjusted EBITDA $27.7M (rolling 12‑month adjusted EBITDA $225M vs $182.9M), inventory $1.1B, operating cycle 173 days (+13 days YoY), cash $175.9M with no ABL borrowings, notes payable down $52.4M YoY, rolling 12‑month adjusted free cash flow $123.4M and free cash flow adjusted for working capital $28M, leverage improved to 4.9x (from 6.8x) and interest coverage to 1.6x (from 1.4x), while management noted lower‑cost, slower purchasing in key sourcing regions and ongoing work to address upcoming long‑term debt maturities.
Pyxus International Financial Statement Overview
Summary
Despite a return to modest profitability (TTM net margin ~0.6%) and operating profitability near ~7%, fundamentals remain pressured by a steep TTM revenue decline (~-21%), very high leverage (debt-to-equity above 5x), thin equity, and persistently negative operating and free cash flow in the provided statements—indicating elevated funding and refinancing risk.
Income Statement
44NeutralBalance Sheet
28NegativeCash Flow
17Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.34B | 2.41B | 2.48B | 2.03B | 1.91B | 1.64B |
| Gross Profit | 342.42M | 332.30M | 342.98M | 312.33M | 261.02M | 227.06M |
| EBITDA | 189.72M | 196.73M | 181.83M | 160.18M | 117.20M | 45.70M |
| Net Income | 23.11M | 14.57M | 15.17M | 2.66M | -56.75M | -92.00M |
Balance Sheet | ||||||
| Total Assets | 2.02B | 1.69B | 1.50B | 1.66B | 1.58B | 1.70B |
| Cash, Cash Equivalents and Short-Term Investments | 175.91M | 134.34M | 78.25M | 92.57M | 136.73M | 198.78M |
| Total Debt | 1.32B | 963.82M | 877.99M | 1.05B | 1.04B | 1.10B |
| Total Liabilities | 1.84B | 1.51B | 1.34B | 1.51B | 1.44B | 1.52B |
| Stockholders Equity | 167.97M | 174.49M | 160.09M | 142.28M | 137.85M | 175.28M |
Cash Flow | ||||||
| Free Cash Flow | -94.83M | -230.50M | -36.41M | -236.01M | -154.13M | -213.59M |
| Operating Cash Flow | -72.87M | -208.45M | -13.39M | -214.97M | -137.82M | -198.76M |
| Investing Cash Flow | 208.37M | 191.42M | 170.64M | 159.45M | 154.94M | 181.24M |
| Financing Cash Flow | -53.49M | 72.52M | -167.26M | 25.56M | -83.00M | 123.26M |
Pyxus International Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PYYX, the sentiment is Negative. The current price of 2.53 is below the 20-day moving average (MA) of 2.63, below the 50-day MA of 2.87, and below the 200-day MA of 3.00, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 42.67 is Neutral, neither overbought nor oversold. The STOCH value of 29.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PYYX.
Pyxus International Peers Comparison
Overall Rating
BTI68Neutral
PM68Neutral
MO65Neutral
TPB65Neutral- PYYX50Neutral
UVV49Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| BTI | 68Neutral | $132.23B | 15.73 | 13.38% | 5.40% | 4.47% | 117.22% |
| PM | 68Neutral | $325.43B | 30.48 | -119.68% | 2.88% | 7.91% | 24.06% |
| MO | 65Neutral | $129.80B | 16.12 | -279.72% | 5.50% | 2.41% | -7.63% |
| TPB | 65Neutral | $1.35B | 28.28 | 11.93% | 0.47% | 20.10% | -3.19% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| PYYX | 50Neutral | $62.26M | 2.82 | 14.23% | ― | -0.56% | ― |
| UVV | 49Neutral | $1.03B | 54.53 | 1.33% | 7.96% | -3.04% | -81.53% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PYYX | Pyxus International Inc | 2.53 | -0.17 | -6.30% | |
| MO | Altria | 78.03 | 24.95 | 47.00% | |
| BTI | British American Tobacco | 61.52 | 12.03 | 24.30% | |
| PM | Philip Morris International | 208.79 | 69.13 | 49.50% | |
| UVV | Universal Corporation | 41.44 | -6.05 | -12.75% | |
| TPB | Turning Point Brands Inc | 67.31 | -25.97 | -27.84% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 22, 2026